Logo image of WORX

SCWORX CORP (WORX) Stock Fundamental Analysis

NASDAQ:WORX - Nasdaq - US78396V2088 - Common Stock - Currency: USD

0.54  -0.01 (-1.82%)

After market: 0.5458 +0.01 (+1.07%)

Fundamental Rating

1

Taking everything into account, WORX scores 1 out of 10 in our fundamental rating. WORX was compared to 37 industry peers in the Health Care Technology industry. WORX has a bad profitability rating. Also its financial health evaluation is rather negative. WORX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year WORX has reported negative net income.
In the past year WORX has reported a negative cash flow from operations.
In the past 5 years WORX always reported negative net income.
In the past 5 years WORX always reported negative operating cash flow.
WORX Yearly Net Income VS EBIT VS OCF VS FCFWORX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M

1.2 Ratios

The Return On Assets of WORX (-53.82%) is worse than 75.68% of its industry peers.
WORX has a worse Return On Equity (-78.26%) than 62.16% of its industry peers.
Industry RankSector Rank
ROA -53.82%
ROE -78.26%
ROIC N/A
ROA(3y)-41.73%
ROA(5y)-61.6%
ROE(3y)-63.35%
ROE(5y)-96.48%
ROIC(3y)N/A
ROIC(5y)N/A
WORX Yearly ROA, ROE, ROICWORX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K -1K

1.3 Margins

WORX has a worse Gross Margin (28.98%) than 75.68% of its industry peers.
WORX's Gross Margin has been stable in the last couple of years.
WORX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5YN/A
WORX Yearly Profit, Operating, Gross MarginsWORX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

1

2. Health

2.1 Basic Checks

WORX does not have a ROIC to compare to the WACC, probably because it is not profitable.
WORX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WORX has been increased compared to 5 years ago.
The debt/assets ratio for WORX has been reduced compared to a year ago.
WORX Yearly Shares OutstandingWORX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
WORX Yearly Total Debt VS Total AssetsWORX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

WORX has an Altman-Z score of -6.49. This is a bad value and indicates that WORX is not financially healthy and even has some risk of bankruptcy.
WORX has a worse Altman-Z score (-6.49) than 78.38% of its industry peers.
WORX has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
WORX's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. WORX outperforms 62.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -6.49
ROIC/WACCN/A
WACC10.15%
WORX Yearly LT Debt VS Equity VS FCFWORX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.33 indicates that WORX may have some problems paying its short term obligations.
The Current ratio of WORX (0.33) is worse than 86.49% of its industry peers.
A Quick Ratio of 0.33 indicates that WORX may have some problems paying its short term obligations.
WORX's Quick ratio of 0.33 is on the low side compared to the rest of the industry. WORX is outperformed by 86.49% of its industry peers.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.33
WORX Yearly Current Assets VS Current LiabilitesWORX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for WORX have decreased strongly by -65.42% in the last year.
WORX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.96%.
The Revenue has been growing by 90.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-65.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.16%
Revenue 1Y (TTM)-17.96%
Revenue growth 3Y-9.95%
Revenue growth 5Y90.92%
Sales Q2Q%-16.52%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WORX Yearly Revenue VS EstimatesWORX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WORX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WORX Price Earnings VS Forward Price EarningsWORX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WORX Per share dataWORX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

WORX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCWORX CORP

NASDAQ:WORX (4/17/2025, 8:00:02 PM)

After market: 0.5458 +0.01 (+1.07%)

0.54

-0.01 (-1.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-12 2024-11-12
Earnings (Next)09-22 2025-09-22
Inst Owners11.72%
Inst Owner Change0%
Ins Owners3.55%
Ins Owner Change0%
Market Cap1.14M
Analysts0
Price TargetN/A
Short Float %0.96%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 0.25
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.8
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS1.53
BVpS2.13
TBVpS-0.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -53.82%
ROE -78.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.98%
FCFM N/A
ROA(3y)-41.73%
ROA(5y)-61.6%
ROE(3y)-63.35%
ROE(5y)-96.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.74%
GM growth 5YN/A
F-Score4
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.33
Altman-Z -6.49
F-Score4
WACC10.15%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.16%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.96%
Revenue growth 3Y-9.95%
Revenue growth 5Y90.92%
Sales Q2Q%-16.52%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-38.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.96%
OCF growth 3YN/A
OCF growth 5YN/A